destiny pharma |

Alan Green discusses Global Energy Metals Corp #GEMC & Destiny Pharma #DEST on the Stockbox Research podcast

Destiny Pharma #DEST – Developing Novel Medicines that Prevent Serious Infections. Alan Green talks to CEO Neil Clark

Two exciting late stage clinical assets – XF-73 and NTCD-M3 China Medical Systems – new XF-73 programme in China NTCD-M3 Phase 3 studies Spore COV – JV progress and Innovate funding Cash runway and upcoming value inflection points

Alan Green discusses TSX listed AIS Resources $AIS & Destiny Pharma #DEST on the Stockbox Research podcast

Alan Green talks Royal Mail Group #RMG, Destiny Pharma #DEST & ECR Minerals #ECR on the UK Investor Magazine podcast

Alan Green joins the Podcast with Jonathan Roy for the weekly instalment of UK equities and market themes. With the FTSE 100 remaining stubbornly within a tight range, we look back at the appreciation we’ve seen in cyclical shares and whether investors should expect a greater proportion of their returns to be achieved from income in the […]

Alan Green discusses Destiny Pharma #DEST, Union Jack Oil #UJO & Power Metal Resources #POW on Vox Markets podcast

Alan Green discusses Destiny Pharma #DEST, Union Jack Oil #UJO & Power Metal Resources #POW with Justin Waite on the Vox Markets podcast.

Alan Green talks Synairgen #SNG, Destiny Pharma #DEST & Mode Group #MODE on Vox Markets podcast

Alan Green discusses Synairgen #SNG, Destiny Pharma #DEST & Mode Group #MODE with Justin Waite on the Vox Markets podcast. Interview is 12 minutes 40 seconds in.

Alan Green on markets after Biden election, plus Mosman Oil & Gas #MSMN, Eddie Stobart #ESL & Destiny Pharma #DEST on UK Investor Mag podcast

Alan Green joins the UK Investor Magazine Podcast as Joe Biden is inaugurated as the President of the United States. Biden’s inauguration marks the next chapter for equity market, not only because of optimism surrounding stimulus promised by his administration, but because of the removal of the last great uncertainty of 2020. With a Joe […]

Alan Green on metals, oil, Blencowe Resources #BRES, Versarien #VRS & Destiny Pharma #DEST on the UK Investor Magazine podcast

FTSE 100 commodities sector: metals are more attractive than oil @Alan__Green joins the UK Investor Magazine Podcast to discuss Blencowe Resources #BRES Versarien #VRS and Destiny Pharma #DEST

Alan Green talks markets, Bidstack #BIDS, RA International #RAI & Destiny Pharma #DEST on UK Investor Magazine podcast

Alan Green discusses markets, Bidstack #BIDS, RA International #RAI & Destiny Pharma #DEST with Jonathan Roy on the UK Investor Magazine podcast.

Alan Green presents the investment case for Novacyt #NCYT, Avacta #AVCT, Destiny Pharma #DEST & Catenae Innovation #CTEA